The FDA also categorizes which bulk drug substances compounders may use when creating custom medications, and in late 2023, the agency flagged 19 popular peptides BPC-157, TB-500, and others as Category 2 (an FDA designation for bulk drug substances that present significant safety concerns and may no longer be used in compounding), effectively banning them from traditional compounding
Explore our comprehensive DSIP Nasal Spray guide to see how both delivery routes fit into overall sleep and recovery support
Are there any dietary restrictions I should follow while taking this medication
Follow product instructions and clinician guidance
Until more information is available, NAD+ Injection is only initiated in non-pregnant adults, and women of childbearing potential are typically asked about pregnancy status before starting therapy
Some users prefer weekends when they can rest if side effects emerge